Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung Cancer

By Riess Jonathan W.   Logan Aaron C.   Krupitskaya Yelena   Padda Sukhmani   Clément-Duchêne Christelle   Ganjoo Kristen   Colevas A. Dimitrios   Pedro-Salcedo Melanie San   Kuo Calvin J.   Wakelee Heather A.  

Cancer Investigation, Vol. 30, Iss. 3, 2012-02 ,pp. : 231-235

Informa Healthcare

Access to resources Recommend Favorite

Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancermediated malignant pleural effusion

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2332-2340

Spandidos Publications

Access to resources Recommend Favorite

Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions

By Xu Chun-Hua   Zhan Ping   Yu Li-Ke   Zhang Xiu-Wei  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1599-1603

Springer Publishing Company

Access to resources Recommend Favorite

Pemetrexed: A Review of its Use in Malignant Pleural Mesothelioma and Non-Small-Cell Lung Cancer

By Dean M. Robinson   Gillian M. Keating   Antona J. Wagstaff  

American Journal of Cancer, Vol. 3, Iss. 6, 2004-01 ,pp. : 387-399

Adis International

Access to resources Recommend Favorite

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

By Raez Luis   Santos Edgardo   Webb R.   Wade James   Brito Roger   Karr Melissa   Kennah Andra   Childs Barrett  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1103-1110

Springer Publishing Company

Access to resources Recommend Favorite